Jungnik A

References (2)

Title : Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects - Retlich_2010_Clin.Pharmacokinet_49_829
Author(s) : Retlich S , Duval V , Ring A , Staab A , Huttner S , Jungnik A , Jaehde U , Dugi KA , Graefe-Mody U
Ref : Clinical Pharmacokinetics , 49 :829 , 2010
Abstract :
PubMedSearch : Retlich_2010_Clin.Pharmacokinet_49_829
PubMedID: 21053992

Title : Evaluation of the pharmacokinetic interaction between the dipeptidyl peptidase-4 inhibitor linagliptin and pioglitazone in healthy volunteers - Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652
Author(s) : Graefe-Mody EU , Jungnik A , Ring A , Woerle HJ , Dugi KA
Ref : Int J Clinical Pharmacology & Therapeutics , 48 :652 , 2010
Abstract :
PubMedSearch : Graefe-Mody_2010_Int.J.Clin.Pharmacol.Ther_48_652
PubMedID: 20875371